Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Humana Inc (NYSE: HUM) closed the day trading at $310.06 up 2.11% from the previous closing price of $303.66. In other words, the price has increased by $2.11 from its previous closing price. On the day, 1.97 million shares were traded. HUM stock price reached its highest trading level at $314.28 during the session, while it also had its lowest trading level at $303.012.
Ratios:
For a better understanding of HUM, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.69.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 37291536384 and an Enterprise Value of 28565479424. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.80, and their Forward P/E ratio for the next fiscal year is 22.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 2.05. Its current Enterprise Value per Revenue stands at 0.232 whereas that against EBITDA is 7.115.
Stock Price History:
The Beta on a monthly basis for HUM is 0.44, which has changed by -0.16515887 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $382.72, while it has fallen to a 52-week low of $206.87. The 50-Day Moving Average of the stock is 21.24%, while the 200-Day Moving Average is calculated to be 18.40%.
Shares Statistics:
Over the past 3-months, HUM traded about 1.67M shares per day on average, while over the past 10 days, HUM traded about 1270650 shares per day. A total of 120.27M shares are outstanding, with a floating share count of 119.99M. Insiders hold about 0.23% of the company’s shares, while institutions hold 95.52% stake in the company. Shares short for HUM as of 1755216000 were 5265970 with a Short Ratio of 3.16, compared to 1752537600 on 4277616. Therefore, it implies a Short% of Shares Outstanding of 5265970 and a Short% of Float of 4.9099997.
Dividends & Splits
HUM’s forward annual dividend rate is 3.54, up from 3.54 a year ago. Against a Trailing Annual Dividend Yield of 0.011657774The stock’s 5-year Average Dividend Yield is 0.83. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-06-27 with an ex-dividend date of 2025-09-26. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The stock of Humana Inc (HUM) is currently drawing attention from 22.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$3.74, with high estimates of -$2.74 and low estimates of -$4.43.
Analysts are recommending an EPS of between $17.26 and $16.18 for the fiscal current year, implying an average EPS of $16.93. EPS for the following year is $13.63, with 24.0 analysts recommending between $15.85 and $10.42.
Revenue Estimates
15 analysts predict $31.98B in revenue for the current quarter. It ranges from a high estimate of $32.2B to a low estimate of $31.4B. As of the current estimate, Humana Inc’s year-ago sales were $29.4BFor the next quarter, 15 analysts are estimating revenue of $31.85B. There is a high estimate of $32.38B for the next quarter, whereas the lowest estimate is $31.07B.
A total of 18 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $129.03B, while the lowest revenue estimate was $126.97B, resulting in an average revenue estimate of $128.18B. In the same quarter a year ago, actual revenue was $117.76BBased on 18 analysts’ estimates, the company’s revenue will be $134.39B in the next fiscal year. The high estimate is $145.97B and the low estimate is $121.6B.
